Supply Chain
ECRI Institute, an independent nonprofit that researches the best approaches to improving patient care, announced the winners of its first-annual Healthcare Supply Chain Achievement Award.
The Federal Trade Commission has dismissed its lawsuit against Omnicare after the long-term care pharmacy provider dropped its hostile bid to take over rival PharMerica.
The Food and Drug Administration today announced the steps it is taking to end the shortage of two important cancer drugs.
As the FDA issued draft guidance on biosimilar product development, a new report finds the global market for biosimilars is forecast to reach $4.8 billion by the year 2015.
Steven Chyung, vice president of supply chain management for Sisters of Charity of Leavenworth Health System, spoke recently with Healthcare Finance News Contributing Writer Betsy Caron about what he expects to be the major supply chain management trends in 2012.
When it comes to supply chain management, it isn’t just about moving boxes anymore, said Ed Raeke, director of materials management at Massachusetts General Hospital. Spending trends in 2012 will move toward reducing operating expenses for hospitals by effectively using the analytics and tools offered by GPOs.
For every dollar spent on over-the-counter (OTC) medicines, the U.S. healthcare system saves six to seven dollars, providing $102 billion in value annually, says a new report from the Consumer Healthcare Products Association (CHPA).
Doctors' lack of brand loyalty costs Big Pharma billions of dollars annually because doctors prescribe generics as soon as they become available, says a new survey from marketing solutions firm DoctorDirectory.
The Federal Trade Commission filed a lawsuit Friday seeking to block long-term care pharmacy services company OmniCare Inc.'s hostile takeover attempt of rival PharMerica Corp.
New drugs in three multi-billion dollar categories will help pharmaceutical companies offset patent expirations and will ease pressure on credit rating outlooks, says a new report from Moody's Investors Service.